Treatment with NAD(+) inhibited experimental autoimmune encephalomyelitis by activating AMPK/SIRT1 signaling pathway and modulating Th1/Th17 immune responses in mice.
Wang J, Zhao C, Kong P, Sun H, Sun Z, Bian G, Sun Y, Guo L
Int Immunopharmacol. 2016 Aug 5; 39:287-294. PMID: 27500459.Abstract